Research Overview: Tamoxifen-Teva 10/60 Teva Pharmaceutical
Tamoxifen-Teva 10/60 is a pharmaceutical-grade selective estrogen receptor modulator (SERM) manufactured by Teva Pharmaceutical Industries. This non-steroidal compound acts as a competitive antagonist at estrogen receptors in breast tissue whilst functioning as an agonist in bone and endometrium research models. The Teva formulation represents a clinically-validated reference standard widely employed in estrogen receptor binding studies and hormonal pathway research. Researchers studying endocrine disruption, cell signalling pathways, and receptor pharmacology frequently utilise this compound in controlled laboratory environments. Stroid UK Shop maintains strict quality standards for all pharmaceutical compounds sourced from established manufacturers like Teva.
Research Applications
This compound serves as an invaluable tool for investigating estrogen receptor mechanisms across multiple tissue types. Cell culture studies examine tamoxifen’s differential effects on ER-alpha and ER-beta receptor subtypes, providing insights into tissue-selective modulation. Molecular biology researchers investigate the compound’s influence on gene expression profiles, particularly those regulated by estrogen response elements. Pharmacokinetic studies evaluate tamoxifen metabolism pathways, including formation of active metabolites through cytochrome P450 enzymes. Research protocols examining aromatase inhibitors and SERMs often incorporate tamoxifen as a reference compound for comparative analysis. Advanced studies explore its role in modulating growth factor signalling and cell cycle progression across various experimental models.
Technical Specifications
| Parameter | Value |
|---|---|
| CAS Number | 54965-24-1 |
| Molecular Formula | C₃₂H₃₇NO₈ |
| Molecular Weight | 563.64 g/mol |
| Manufacturer | Teva Pharmaceutical |
| Package Configuration | 10mg/60 tablets |
| Storage Conditions | Room temperature, protect from light |
| Compound Class | Non-steroidal SERM |
This pharmaceutical preparation maintains consistent potency through Teva’s validated manufacturing processes. Storage recommendations ensure compound stability throughout research timelines. Researchers working with SARMs and peptides often require reliable SERM compounds for comparative hormonal studies.
Compliance Statement
Tamoxifen-Teva 10/60 is intended exclusively for in-vitro research purposes and laboratory analysis. This pharmaceutical compound is not authorised for human consumption, clinical use, or veterinary applications. Researchers must ensure appropriate institutional oversight and safety protocols when handling this material. All studies should comply with relevant laboratory safety guidelines and institutional research ethics requirements. Purchase and possession should align with applicable research licensing and regulatory frameworks governing laboratory chemicals.
